A delegation of seven professors from Australian universities recently travelled to China to promote joint research in the musculoskeletal disciplines. [ + ]

Qiagen has acquired an exclusive worldwide licence to the biomarker calreticulin (CALR), whose mutations are found in an estimated 15% of cases of myeloproliferative neoplasms (MPNs) - a group of blood disorders involving overproduction of blood cells. [ + ]

UQ spinoff Spinifex has raised $47.7m in series C investment funding to help accelerate the clinical development of neuropathic and inflammatory pain drug EMA401. [ + ]

Olympus Australia has moved its operational headquarters to a state-of-the-art facility in Melbourne that incorporates a fully operational customer experience centre, comprehensive training facilities and the company's national service centre. [ + ]

Australian biotech company Spinifex Pharmaceuticals has attracted $48 million in funding to advance its drug for chronic pain, EMA401. The deal represents one of Australia's largest off-market investments in a private biotechnology company. [ + ]

Wild rainbowfish are more courageous than those raised in captivity, according to a study. [ + ]

AstraZeneca has arranged to evaluate using Starpharma's DEP dendrimer drug delivery technology for a second cancer drug. [ + ]

Insights into how platelet production is managed in the blood have been reported. [ + ]

Three biomedical animations that have been a year in the making are having their debut on screen. [ + ]

Osprey Medical's (ASX:OSP) Limb Recovery System reduced bacterial load in patients with diabetic foot infections during a pilot trial - so much so that one patient escaped the need for amputation. [ + ]

Biotech and medtech leaders are participating this week and next in focus groups to share their views and perspectives on industry policy and bolster the 2014 Biotechnology Industry Position Survey, due for release in May. [ + ]

The skull reconstruction of an extinct carnivorous marsupial suggests it had the ability to hunt prey much larger than itself. [ + ]

Researchers from La Trobe University have found that the natural defence mechanisms of a tobacco plant could be harnessed to kill cancer cells in the human body. [ + ]

Avita Medical (ASX:AVH) announced the EU launch of a version of its ReCell Spray-on Skin that eliminates the requirement for refrigeration, but the new version is not yet approved in Australia. [ + ]

Minomic International has tapped CUSP Group to help conduct two US trials of MiSat, a prostate cancer screening tool which has shown signs of being more accurate than the standard PSA test. [ + ]